Palladium Pd-103 is a radioactive isotope used in brachytherapy, most commonly for prostate cancer. It emits low-energy photons and has a short half-life (~17 days), enabling effective localized radiation with minimal damage to surrounding tissues. The directory classifies it as a commercial API with a mineral/inorganic source/manufacturing origin. Other names for this substance include Pd-103 radioisotope and radioactive palladium. Its PubChem CID is 9793711.
Palladium Pd-103
| CAS No | 14967-68-1 |
|---|---|
| Molecular Formula | Pd |
| Molecular Weight | 102.91 g/mol |
| Synonyms | palladium-103 |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Palladium Pd-103 is a radioactive isotope used in brachytherapy, most commonly for prostate cancer. It emits low-energy photons and has a short half-life (~17 days), enabling effective localized radiation with minimal damage to surrounding tissues.
The listed CAS number is 14967-68-1.
The listed molecular formula is Pd.
The listed molecular weight is 102.91 g/mol.
palladium-103.
The source lists Pd-103 radioisotope and radioactive palladium.